logo
Select company
Select metric
-129.01%EBITDA Margin
VS
Market
11
Sector
35
Industry
62
History
83
$ 7.81Close
$ 5.48 - $ 16.44 52-Week Range
Ticker Information

Ticker

WVE

Company Name

WAVE LIFE SCIENCES LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

WAVE LIFE SCIENCES LTD - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

WVE - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -121.2M-129.01%$ 93.95M
3/31/2025$ -103.68M-98.8%$ 104.94M
12/31/2024$ -88.34M-81.57%$ 108.3M
9/30/2024$ -133.83M-249.63%$ 53.61M
6/30/2024$ -65.37M-59.16%$ 110.5M
3/31/2024$ -53.4M-47.29%$ 112.91M
12/31/2023$ -48.98M-43.23%$ 113.31M
9/30/2023$ -75.44M-88.25%$ 85.49M
6/30/2023$ -120.69M-330.11%$ 36.56M
3/31/2023$ -140.69M-948.85%$ 14.83M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • WAVE LIFE SCIENCES LTD's latest trailing twelve months (TTM) EBITDA % stands at -1288.45%.
  • Over the past 5 years, WAVE LIFE SCIENCES LTD's average EBITDA % has been -717.94%.
  • The median EBITDA % for WAVE LIFE SCIENCES LTD during this period was -263.22%
  • WAVE LIFE SCIENCES LTD reached its highest EBITDA % over the past 5 years at -43.23%.
  • The lowest EBITDA % recorded by WAVE LIFE SCIENCES LTD in the same timeframe -4138.89%

WAVE LIFE SCIENCES LTD's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
URGN : UROGEN PHARMA LTD -142.56%SPRY : ARS PHARMACEUTICALS INC -41.94%NRIX : NURIX THERAPEUTICS INC -269.44%SNDX : SYNDAX PHARMACEUTICALS INC -400.81%NTLA : INTELLIA THERAPEUTICS INC -889.28%GYRE : GYRE THERAPEUTICS INC 9.65%ZYME : ZYMEWORKS INC -44.4%NAGE : NIAGEN BIOSCIENCE INC 17%CRMD : CORMEDIX INC 43.01%ABCL : ABCELLERA BIOLOGICS INC -404.33%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for WAVE LIFE SCIENCES LTD is calculated as follows: EBITDA [ $ -167.99M ] / Revenues [ $ 13.04M ]
(=) EBITDA % [ -1288.45% ]

WVE - EBITDA Margin, Last 5 years

-4138.89%

Minimum

Dec 31, 2022

-43.23%

Maximum

Dec 31, 2023

-717.94%

Average

-263.22%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%